Eli Yaffe
Analyst · Etzioni Portfolio Management
Thank you. Good morning. Thank you for joining us for our 2025 second quarter earnings call. With me is Ron Freund, our Chief Financial Officer. We will begin by providing you with an overview of our business and summary of the principal factors that affected our results during Q2 2025. After our prepared remarks, we will be happy to answer any of your questions. By now, everyone should have access to our press release, which was released earlier today. The release will be also available on our website. Let me start with the financial highlights. Revenues for the second quarter of 2025 totaled $12.5 million, representing 20% increase compared to the same period last year and maintaining the strong momentum seen in Q1 2025. For the first half of 2025, revenues reached $25.3 million, up from $22.2 million in the first half of 2024. This performance indicates early signs of stabilization in our production capacity and improved run rate. As previously communicated, our accelerated investment program objective was to scale our installed production capacity to support $55 million to $65 million in annual revenue. Gross profit totaled $3 million, nearly double the results from the same quarter last year. Gross margin expanded to 24.1%, up from 15.6% in Q2 2024, driven by improved operational efficiencies and more favorable product mix. With production process stabilization and all installed equipment now fully operational, our fixed cost base is largely absorbed. As a result, incremental revenue is expected to have significant stronger impact on profitability, potentially contribute approximately $0.50 on a dollar to our gross profit. Operational income rose to $1.5 million, up from $0.4 million in Q2 2024. During the quarter, we recorded onetime financial expenses of $1 million, resulting from a 9% devaluation of the U.S. dollar against the Israeli shekel. While we do not anticipate similar currency shift in the near term, we have proactively adjusted our pricing model to better align with our new NIS-dominate cost structure. This is nonrecurring expenses impacted by our bottom line, resulting in net income of $0.4 million or $0.05 per fully diluted shares. EBITDA reaches $2 million and represent 15.6% of revenue, a significant decrease compared to Q2 2024 and Q1 2025. Let me now move to business development and operational updates. From the market perspective, we saw a modest increase in commercial sales alongside continued strong performance in our defense and medical markets. Expanding commercial sales remains a strategic priority as they are less constrained by the current production capacity. We believe that these efforts will yield more substantial results in the near future. Worldwide, lead time for the relevant market sectors remain extended, primarily due to the capacity and operational limitation. As part of our broader capacity expansion strategy, I would like to share progress on several key infrastructure initiatives. All equipment delivered to date has been successfully installed and is in operation in line with the performance specification. The centerpiece of our investment plan, the new 40-meter coating line is now expected to arrive towards the end of 2025 with qualification and ramp-up schedule to begin immediately upon arrival. Supporting infrastructure, including an auxiliary equipment is in the track to be completed by the year-end to ensure fully operational readiness. In parallel, we are investing in additional infrastructure to accommodate future growth. Recently completed a major upgrade to our cooling system, now providing 20% surplus in capacity to support anticipated clean room expansion and redundancy. In addition, we are now in the final stage of increasing electrical capacity by 40%, enabling us to support the next phase of our expansion road map. We continue to face the challenges in recruiting qualified manufacturing personnel. To address this, we have recently submitted a formal request to participate in Israeli government program that support the defense industry by enabling the employment of foreign workers. If approved and subject to our regulatory clearance and completion of the training, these workers will enable us to operate in production lines 7 days a week, significantly enhancing our manufacturing flexibility and capacity to meet the growing demand for the defense-related products. I will now turn the call over to Ron Freund, our CFO, to discuss our financial results.